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Pascal Michel1,4, Jean-Philippe Waaub2 and Denise Bélanger1
Abstract
Background: Zoonoses are a growing international threat interacting at the human-animal-environment interface
and call for transdisciplinary and multi-sectoral approaches in order to achieve effective disease management. The
recent emergence of Lyme disease in Quebec, Canada is a good example of a complex health issue for which the
public health sector must find protective interventions. Traditional preventive and control interventions can have
important environmental, social and economic impacts and as a result, decision-making requires a systems
approach capable of integrating these multiple aspects of interventions. This paper presents the results from a
study of a multi-criteria decision analysis (MCDA) approach for the management of Lyme disease in Quebec,
Canada. MCDA methods allow a comparison of interventions or alternatives based on multiple criteria.
Methods: MCDA models were developed to assess various prevention and control decision criteria pertinent to a
comprehensive management of Lyme disease: a first model was developed for surveillance interventions and a
second was developed for control interventions. Multi-criteria analyses were conducted under two epidemiological
scenarios: a disease emergence scenario and an epidemic scenario.
Results: In general, we observed a good level of agreement between stakeholders. For the surveillance model,
the three preferred interventions were: active surveillance of vectors by flagging or dragging, active surveillance of
vectors by trapping of small rodents and passive surveillance of vectors of human origin. For the control
interventions model, basic preventive communications, human vaccination and small scale landscaping were the
three preferred interventions. Scenarios were found to only have a small effect on the group ranking of
interventions in the control model.
Conclusions: MCDA was used to structure key decision criteria and capture the complexity of Lyme disease
management. This facilitated the identification of gaps in the scientific literature and enabled a clear identification
of complementary interventions that could be used to improve the relevance and acceptability of proposed
prevention and control strategy. Overall, MCDA presents itself as an interesting systematic approach for public
health planning and zoonoses management with a “One Health” perspective.
Keywords: Lyme disease, Lyme borreliosis, Multi-criteria decision analysis, Lyme disease prevention, Vector-borne
diseases, Zoonoses, Public health decision-making
* Correspondence: cecile.aenishaenslin@umontreal.ca
1Groupe de Recherche en Épidémiologie des Zoonoses et Santé Publique
(GREZOSP), Pavillon de la santé publique, Faculté de médecine vétérinaire,
Université de Montréal, Saint-Hyacinthe CP 5000, Québec, Canada
Full list of author information is available at the end of the article
© 2013 Aenishaenslin et al.; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the
Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use,
distribution, and reproduction in any medium, provided the original work is properly cited.
Aenishaenslin et al. BMC Public Health 2013, 13:897
http://www.biomedcentral.com/1471-2458/13/897
Background
Zoonoses, and more generally infectious diseases arising
from the interaction of human populations with animals
and the environment, are a growing international public
health threat that is likely to increase with ongoing glo-
balisation and climate change. Currently, these diseases
represent three quarters of all recognized emerging
infectious diseases [1]. Recent outbreaks of avian in-
fluenza and SARS had expensive and multi-sectoral
consequences across continents [2,3]. The worldwide
emergence of bovine spongiform encephalopathy and
West Nile virus (WNv) in North America are two ad-
ditional examples of such diseases that have caused
widespread concern with the general public and deci-
sion makers [4,5].
Interacting at the human-animal-environment inter-
face, zoonoses that involve vectors and wildlife species
have particular characteristics making them difficult to
prevent and control. On the one hand, they involve mul-
tiple species, often with complex ecologies, making con-
trol or eradication very difficult. On the other hand,
because of this ecological complexity, preventive and
control interventions of zoonoses can have environmen-
tal, social and economic impacts. For example, larvicides
used in attempts to control WNv during the 1999–2007
outbreak in Canada were found to be toxic for some
wild bird and fish species, and their use was publicly
criticized by local media and experts [6]. Moreover, zoo-
noses pose important prevention and control challenges
because multiple organisations and stakeholders share
responsibilities with regards to public health actions;
however, the implementation and anticipated effects of
cross-sectoral interventions can be more difficult to pre-
dict for strategic planners and decision-makers. This
complexity calls for transdisciplinary and multi-sectoral
approaches in order to achieve effective disease manage-
ment, a call which can no longer be ignored [7].
A “One Health” approach is needed to develop effective
management for zoonoses. The “One Health” approach
recognizes the intimate linkages between human, animal
and environmental health systems and proposes an inter-
national, interdisciplinary, and cross-sectoral approach to
disease surveillance, monitoring, prevention, control and
mitigation of emerging and re-emerging diseases [8]. In
recent years, this approach has been adopted by several
national and international organisations as a promising
way to improve public health interventions [9,10].
Multi-criteria decision analysis (MCDA) methods
come from the field of operations research and are com-
monly used in environmental, industrial and business
management [11,12]. Multiple MCDA algorithms exist
to analyse different types of decision problems, one of
which consists of ranking and comparing alternatives
based on multiple criteria that can be evaluated using
either quantitative and/or qualitative indicators [13]. In
the absence of quantitative data for a criterion in a
specific context, MCDA methods allow for the incor-
poration of qualitative evaluations, for example based on
expert opinion. Moreover, it offers the possibility, if
needed, for a participatory approach with stakeholders
concerned by a particular issue, allowing them to ac-
tively engage in all stages of the decision analysis sup-
ported by MCDA. As such, MCDA methods are well
suited for complex, transdisciplinary and multi-sectoral
decision-making problems such as zoonotic disease
management [14,15]. The use of MCDA in public health
has thus far been limited but is emerging as a comple-
mentary method for evidence-based public health
[16-18]. It has been used in different contexts, such as
for the prioritization of general health issues, including
zoonoses [17-23], and to compare potential alternatives
or interventions for public health management. For this
later goal, most published studies have been in the field
of environmental health, but some more recent studies
were done to prioritize interventions for infectious dis-
eases management [24-26]. Fewer studies have
attempted to confront zoonotic or animal related disease
problems with an MCDA approach: one such study used
MCDA to compare strategies for the elimination of car-
casses following a hypothetical event of food-industry
targeted terrorism [27], another used MCDA to compare
different methods of quarantine and control during
animal disease epidemics [28,29]. Hongoh and col-
leagues [30] proposed a general model and discussed the
potential strengths of the use of MCDA methods for
vector-borne disease management with explicit spatial
considerations.
Lyme disease, a zoonosis caused by the bacteria
Borrelia burgdorferi and transmitted to humans via the
bites of ticks infected from animal reservoirs, is one of
the most common vector-borne diseases in temperate
countries and is a good example of a public health issue
at the human-animal-environment interface [31]. The
incidence of Lyme disease has been increasing annually
in North America, particularly in the north-eastern
United States where more than 20,000 cases are reported
annually [31]. In the Canadian province of Quebec, the
incidence of Lyme disease has thus far been low (0.5 per
100 000 in 2011 according to a recent report by the
Quebec National Institute of Public Health [32] com-
pared to rates of 60.3, 67.3 and 76 per 100 000 in the
same year in the neighbouring states of Maine, New
Hampshire and Vermont respectively [33]), but could
grow to 8 000 cases annually by 2050 in the southeast
and the central southern parts of Canada [34-37]. The
first autochtonous human case of Lyme disease in
Quebec was reported in 2008 (Quebec National Institute
of Public Health, unpublished observations). Black
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legged tick populations, the vector of B. burgdorferi, are
now recognized as having become established in the
southern part of the province, with up to 13% of ticks
infected with B. burgdorferi [37]. Given these changing
dynamics, the Quebec public health authorities have
expressed the desire to proactively respond to this public
health concern and to develop a Lyme disease manage-
ment plan. As such, this is an ideal context for the use
of MCDA methods for zoonotic disease management. In
the Quebec health system, public health responsibilities,
including Lyme disease prevention, are shared between
provincial and regional public authorities. The Ministry
of Health and Social Services, supported by the National
Institute of Public Health in Quebec, is the provincial
authority and first level responsible for applying pro-
vincial public health programs in collaboration with
regional authorities [38]. Each of the 18 administrative
regions of the province has their own Health and Social
Services Agency. No province-wide program for Lyme
disease management currently exists due to the fact that
the disease is presently only concentrated in the sou-
thern part of Quebec and has affected only a few re-
gions. This article aims to present the context, goals,
methods and results from a study of the use of MCDA
for Lyme disease management in Quebec, Canada.
Methods
The study was conducted between September 2010 and
February 2012 with the general objective of identifying,
evaluating and ranking different strategies for Lyme
disease management in Quebec, in order to support
decision-making and program direction by public health
authorities. A research team composed of senior and
junior researchers active in the fields of public health,
veterinary public health and decision analysis research
was assembled specifically for this study.
Three main intervention areas were first identified to
address Lyme disease management in a comprehensive
manner (see the result section for the detailed research
questions): preventive communication strategies (COMM),
surveillance strategies (SURV) and control strategies
(CONT). Preventive communication strategies refers to
all modes of communication implemented by public
health authorities to prevent Lyme disease in humans;
surveillance strategies refers to vector, animal and hu-
man related surveillance activities designed to monitor
the disease and the state of the infection in the reser-
voir and the vector; and control strategies refers to field
interventions which can be implemented to reduce the
risk of transmission of the infectious agent to humans.
This article will focus on the results from the MCDA
approach applied to the ranking of surveillance and
control strategies. Analyses of communication strategies
with MCDA will not be presented in the present paper
as they required a slightly different methodological
framework. The term ‘intervention’ will be use to refer
to the specific strategies included in this study for sur-
veillance and control.
The MCDA process used for this study can be divided
into ten general steps, each with specific methods (Figure 1).
These ten steps are non-linear and may require a few iter-
ations. For example, the identification and inclusion of
certain strategies in the model can lead to the inclusion of
additional stakeholders in the group as was the case for
1. Define problem
2. Identify stakeholders
3. Identify key decision 
issues
4. Define criteria and 
indicators
5. Identify interventions
or strategies to 
compare
Problem structuring 
(Steps 1 to 7)
6. Evaluate 
performance of 
strategies 
7. Weight criteria 
under specific 
scenarios
8. Multi-criteria 
analysis based on 
the constructed 
matrix
9. Sensitivity analysis
10. Interpretation of 
results
Decision Analysis
(Steps 8 to 10)
• List of key stakeholders
• List of criteria
• List of interventions or 
strategies
• Matrix of evaluation of 
interventions on all 
criteria
• Stakeholder weighting 
schemes for all 
scenarios
• Group and individual 
rankings of 
interventions
• Intervention profiles
• Decision maps 
• Identification of 
stakeholder 
convergence and 
divergence points
• Sensitivity of results to 
given weightings 
Output produced
•Performed by participatory approach: 
focus groups, individualinterviews, questionnaires. 
• Performed by MCDA experts: 
MCDA software.
Figure 1 MCDA general steps and outcomes.
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our project. A participatory approach (focus groups, indi-
vidual interviews, questionnaires) with a group of stake-
holders was adopted for this study. A stakeholder was
defined as a person representing an organisation or a
group with direct responsibilities or with specific interests
in Lyme disease management. This included representa-
tives of governmental or non-governmental organisations,
health professionals and experts (different from the
research team). Stakeholders were asked to represent the
preferences of their organisation and not their own pre-
ferences. To make this possible, they were invited to con-
sult other colleagues in their organisation throughout the
MCDA process. Stakeholders participated most inten-
sively in the problem definition stage, identification of the
extended stakeholders group, identification of key decision
issues, translation of these issues into measurable criteria,
identification of Lyme disease intervention strategies
(steps 1 to 5) and weighting of the criteria (step 7).
The identification of issues (step 3), the definition of cri-
teria (step 4) and the selection of interventions (step 5)
were done using an iterative process with the stakeholders:
the research group proposed a first set of interventions
and criteria along with their definitions, indicators for
each criteria and appropriate measurement scales based
on their understanding of the major surveillance and con-
trol issues for Lyme disease. This initial set was discussed
and modified by the stakeholders by means of a focus
group discussion. The final versions of the criteria (name,
definition, indicator, measurement scales) and interven-
tions lists were then validated by each stakeholder using a
web-based questionnaire.
The evaluation of performance parameters for the
retained list of interventions was carried out over each
criterion (step 6) using literature supported data when
available. When data were not available to evaluate
parameters for criteria, Delphi surveys were conducted
with stakeholders (CONT model) and external experts
(SURV model). If there was no consensus on parameters
after two iterations of the Delphi process, the mean
value was selected. For the CONT model, selected stake-
holders and members of the research team were con-
sulted as experts for the determination of parameters.
For the SURV model, a group of three external experts
in Lyme surveillance were consulted.
Individual weighting of all criteria was done by each
stakeholder under two different scenarios (step 7). The
first scenario described the current epidemiological si-
tuation of Lyme disease in Quebec (referred to as
“emergence scenario”). The second scenario described a
hypothetical substantial increase in the annual number
of human cases of Lyme disease in Quebec, coupled
with more intensive media coverage and public aware-
ness (referred to as “epidemic scenario”). Each stake-
holder was asked to create model-specific weighting
schemes based on the stakeholder’s perceived impor-
tance of criteria for decision-making in line with their
organisational affiliation. This was done by first distri-
buting 100 points among the criteria categories and
then re-distributing the category specific points to all
criteria within each category. A tool was created using
Excel software version 2007 to facilitate this exercise.
Individual support was offered to stakeholders to com-
plete the weighting when needed to ensure a good com-
prehension of the process.
Decision analysis (steps 8 to 10) was carried out in D-
Sight (software version 3.3.2) which uses the PROMETHEE
(Preference Ranking Organization Method for Enrichment
Evaluations) methods and gives access to the GAIA (Geo-
metrical Analysis for Interactive Aid) visual model to
explore analysis results [39-41]. PROMETHEE methods
enable fully comparative rankings of a set of alternatives
[11]. The decision map, which is called a GAIA plan and
is generated by the D-sight software, is a two-dimensional
graphical representation of a stakeholder’s position, dic-
tated by their individual preferences (ranking of interven-
tions). The decision map is referenced with a decision axis
(in red), which points toward the “best” interventions in
accordance with the group scores of interventions on all
included criteria. The proximity of stakeholder’s positions
within the GAIA plan represents proximity in their overall
preferences. This graphical representation of stakeholder
values can be used to identify potential coalitions or clus-
ters of positions among stakeholders and to identify posi-
tions that are distinctive from that of other stakeholders
by their distances in relation to others or to the decision
axis. Similarly to positioning stakeholders, the GAIA plan
also positions all interventions in relation to the overall
decision axis. Multi-criteria analyses carried out in D-sight
assess the performance of interventions over all criteria
resulting in numerical scores for each intervention. D-
sight uses specific algorithms based on a pair wise method
of analysis to calculate scores (PROMETHEE I and II)
[33]. The intervention scores and weighting schemes set
by stakeholders can be combined to produce three sets of
results of particular interest in our study: 1) group ran-
kings of the interventions, representing an ordered rank-
ing of most preferred to least preferred intervention that
takes all weighting schemes and intervention performance
scores into account; 2) individual rankings for each stake-
holder, representing the most preferred to least preferred
intervention for a particular stakeholder given their spe-
cific weighting scheme; and 3) individual performance of
interventions for every criterion, showing how an inter-
vention performs on every criterion independently of all
stakeholder weighting schemes. Intervention scores repre-
sent the relative performance of an intervention with
respect to another, and as such scores do not have indi-
vidual meanings by themselves. The objective of these
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scores is to provide a common numeric value to enable
comparisons of interventions. Further details on MCDA
methods have been published by Figueira and col-
leagues [42].
Analyses presented in this paper include group
rankings and individual performance of selected inter-
ventions, as well as decision maps of stakeholder’s pre-
ferences for particular interventions (GAIA planes), and
an example of a sensitivity analysis of one stakeholder’s
weighting schemes. Each of the 10 MCDA steps was
conducted separately for each intervention area (SURV
and CONT). Results for the first 5 steps will be pre-
sented using SURV and CONT models and a more in
depth illustration will be presented for steps 6 to 10
using the CONT model.
Results
Problem definition and identification of stakeholders
(Steps 1 & 2)
To address the general problem of identifying, evaluating
and ranking different strategies for Lyme disease manage-
ment in Quebec, five governmental and one academic or-
ganisations involved in Lyme disease management were
identified and invited to participate in the MCDA process.
Eight representative stakeholders agreed to participate.
The composition of the group was defined in order to
capture the multidisciplinary nature of Lyme management
(Table 1). For the examination of surveillance and control
strategies, two models were developed to address two spe-
cific research questions identified by the stakeholders:
1) what strategies are most effective for Lyme disease sur-
veillance? (SURV model); and 2) what interventions are
most effective for the prevention and control of Lyme
disease? (CONT model). In the context of this study, ef-
fectiveness represents the overall relative performance of
strategies and interventions over multiple decision criteria,
taking into account their importance as defined by the
stakeholders for the Quebec context.
Criteria (Steps 3 & 4)
Sixteen criteria were selected for the two models to
evaluate the effectiveness of interventions relative to the
main issues of Lyme surveillance and control (Table 2).
These criteria were divided into five general categories:
public health criteria (PHC), animal and environmental
health criteria (AEC), social impact criteria (SIC), stra-
tegic, economic and operational impact criteria (SEC)
and surveillance criteria (SUC). Indicators were defined
for each criterion and used qualitative scales for meas-
urement. Categorical ordinal scales were used for all cri-
teria, except for AEC1 and AEC2 where a multiplicative
indicator was defined.
Strategies and interventions (Step 5)
For the SURV model, 11 interventions were identified and
consisted of various passive and active surveillance stra-
tegies targeting vectors, domestic animals and humans:
passive surveillance of vectors found on humans (SURV1a)
and animals (SURV1b); active surveillance of vectors by
flagging or dragging (SURV2a), by trapping of small
rodents (SURV2b) and from hunted deer (SURV2c); pas-
sive surveillance of domestic animals seropositive cases of
B. burgdorferi funded by the animal owners (SURV3a),
funded by the private sector (industry) (SURV3c) or
funded by the public sector (SURV3b); active surveillance
of cases of Lyme disease in domestic animals (SURV4);
passive surveillance of suspected and confirmed cases of
Lyme disease in humans (SURV5); sentinel surveillance of
suspected cases in humans (SURV6). For the CONT
model, 16 interventions were selected, again with the aim
to compare different approaches for Lyme disease preven-
tion and control targeting vectors, vector hosts and human
populations. Vector targeted interventions included: small
(CONT1a) and large (CONT1b) scale acaricide applica-
tions, dessicants/insecticidal soap applications (CONT2),
removal of tick habitats by small scale landscaping border-
ing houses and alleys (CONT3a) or by large scale land-
scaping in public forested areas (CONT3b). Vector host
targeted interventions included: the use of ‘4-poster’
device to control tick infestation on deer (CONT4) or
feed-administered ivermectin (CONT5), reduction of deer
populations by increased hunting quotas (CONT6a), by
culling (CONTb), or by exclusion of deer from public areas
(CONT7), tick control on small rodents by ‘Damminix’
device (CONT8) or fipronil application (CONT9). Human
population targeted interventions included: exclusion
of people from high risk areas (CONT10), vaccination
(CONT11), development of Lyme disease clinics to faci-
litate diagnostic and treatment (CONT12)). All selected
CONT interventions have been used in the past to prevent
and control Lyme disease in experimental or real life
contexts. A ‘status quo’ intervention (CONT0) was also in-
cluded to represent a ‘no additional measures taken’ option
Table 1 Composition of the stakeholder group
Models Organisations (number of stakeholders)
SURV and
CONT
Québec National Institute of Public Health (Institut
national de santé publique du Québec): Infectious
diseases sector (2), Environmental health sector (1)
National Public Health Laboratory (Laboratoire
national de santé publique) (1)
Ministry of Agriculture, Fisheries and Food
(Ministère de l’agriculture, des pêcheries et de
l’alimentation du Québec) (1)
Ministry of Natural Resources and Wildlife (1)
Montérégie Regional Board of Health and Social
Services (1)
Academic expert (1)
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where only a basic public communications strategy for
Lyme disease prevention is provided by public health
authorities with dissemination via web sites and occasional
press releases.
Evaluation of performance parameters (Step 6)
Each intervention was evaluated on each of the selected
criteria using the defined measurement scales and
resulting in the creation of two performance matrices,
one for each model (Table 3). Performance parameters
on criteria varied depending on the intervention. For
example, CONT1b (large scale acaricide application)
had the highest parameter value (equal to 48) for cri-
terion AEC1 (impact on habitat), meaning that this
intervention would have the highest impact on habitat
among all interventions included in the matrix. CONT0
(status quo), CONT11 (vaccination) and CONT12 (de-
velopment of Lyme disease clinics to facilitate diagnostic
Table 2 Criteria and measurement scales used in the surveillance (SURV) and control (CONT) models
Category Criteria Scale Model
SURV CONT
Public health
criteria (PHC)
PHC1 Reduction in
incidence of human cases
0: Nil; 1: Low; 2: Moderate; 3: High X
PHC2 Reduction in
entomological risk
0: Nil; 1: Low; 2: Moderate; 3: High X
PHC3 Impacts of
adverse health effects
0: Nil; 1: Indirect effects on mental or social health;
2: Direct effects on physical health
X
Animal and
environmental
health criteria
(AEC)
AEC 1 Impact on habitat Surface*Sensitivity*Intensity1 X
Surface : 1: Nil; 2: Small scale;
3: Large scale; Sensitivity: 1: Nil; 2: Land;
3: Water ; 4: Land and water; Intensity: 1: Nil; 2: Fences;
3: Mowing; 4: Acaricides; 5: Removal of vegetation or burning
AEC 2 Impact on wildlife Number*Species*Intensity2 X
Number: 1: Nil; 2: Effect on specific species;
3: Effect on several species; Species: 1: Nil,
2: low valued species; 3: Highly valued species; Intensity:
1: No effect; 2: Morbidity; 3: Mortality
Social impact
criteria (SIC)
SIC 1 Level of public acceptance 1: Nil; 2: Low; 3: Moderate; 4: High X
SIC 2 Proportion of population benefitting
from intervention
1:<25%; 2:25-50%; 3:50-75%; 4:>75% X
Strategic, economic and
operational impact
criteria (SEC)
SEC1 Cost to the public sector 0: Nil; 1: Low; 2: Moderate; 3: High X X
SEC2 Cost to the private sector 0: Nil; 1: Low; 2: Moderate; 3: High X X
SEC3 Delay before results 1: Days; 2: Weeks; 3: Months; 4: Years X X
SEC4 Complexity 1: Simple (minor institutional changes); X X
2:Intermediate (necessitates new hires); 3: Moderate (necessitate
new work teams in one sector of intervention); 4: Complex
(requires inter-sectoral/inter-institutional changes);
5: Very complex (necessitates creation of new structures or
organisations)
SEC5 Impact on organisation’s credibility 0: Nil; 1: Low; 2: Moderate; 3: High X
Surveillance
criteria (SUC)
SUC1 Detection of zones where
tick populations are present
1: Less than 10%; 2: Low (11-50%); 3: Moderate (51-70%);
4: High (>71%)
X
SUC2 Identification of zones where tick
populations are established
1: Less than 10%; 2: Low (11-50%); 3: Moderate (51-70%);
4: High (>71%)
X
SUC3 Identification of Lyme
endemic zones
1: Less than10%; 2: Low (11-50%);3: Moderate (51-70%);
4: High (>71%)
X
SUC4 Quality of data 1: Poor; 2: Medium; 3: High X
1The score is calculated using a multiplication of three indicators: surface, sensitivity and intensity.
2The score is calculated using a multiplication of three indicators: number, species and intensity.
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and treatment) had the lowest parameter values for cri-
terion AEC1 (equal to 1), meaning that these interven-
tions would have the lowest impact on habitat.
Weighting of criteria (Step 7)
The weighting of the retained criteria varied in accor-
dance with stakeholder values in each of the models and
varied between both scenarios (Table 4). Public health
was the category which generally received the highest
weighting. For the CONT model, under the epidemic
scenario, five stakeholders (S3, S4, S5, S6 and S7) gave
additional weight to the public health criteria at the ex-
pense of other categories. For example, stakeholder S4
respectively assigned 30, 25, 25 and 20 points to the
public health, animal and environmental impacts, social
impacts and strategic, economic and operational criteria
categories under the emergence scenario, but assigned
weightings of 40, 25, 25 and 10 points under the epi-
demic scenario for the same categories.
Decision analysis (Step 8 to 10)
Group rankings of interventions were performed for both
models using the individual stakeholder’s values expressed
via criteria weightings (Table 5). Group scores ranged
from −0.34 to 0.45 for the SURV model and from −0.33 to
0.43 for the CONT model. For both models, the three
preferred interventions were the same regardless of the
epidemiological scenario (emergence or epidemic). For
the SURV model, the three preferred interventions were
SURV2a (active surveillance of vectors by flagging or
Table 3 Performance matrices for the surveillance (SURV) and control (CONT) models
Performance parameters for each criteria
PHC AEC SIC SEC SUC
Intervention PHC1 PHC2 PHC3 AEC1 AEC2 SIC1 SIC2 SEC1 SEC2 SEC3 SEC4 SEC5 SUC1 SUC2 SUC3 SUC4
CONT model CONT0 1 0 0 1 1 3 4 1 0 3 1 1 N/A
CONT1a 2 3 2 16 8 2 1 1 1 2 4 3
CONT1b 2 3 2 48 18 2 4 2 0 2 4 3
CONT2 1 2 2 24 8 2 1 1 0 2 4 2
CONT3a 2 3 1 20 4 3 1 1 0 2 4 2
CONT3b 2 3 2 30 9 2 1 1 0 2 4 3
CONT4 2 3 2 3 12 3 1 2 1 4 4 2
CONT5 1 2 2 3 12 3 1 1 1 4 4 3
CONT6a 0 2 2 3 18 2 2 0 0 4 4 3
CONT6b 1 2 2 3 27 1 2 2 0 4 4 4
CONT7 1 2 0 12 6 3 1 2 2 4 4 2
CONT8 0 1 2 3 8 3 1 2 1 3 4 2
CONT9 0 1 2 3 8 3 1 2 1 3 4 2
CONT10 1 0 0 3 1 3 3 0 0 2 4 3
CONT11 2 0 2 1 1 3 3 1 0 2 5 2
CONT12 0 0 0 1 1 4 3 1 0 2 5 2
SURV model SURV1a N/A 2 1 3 1 N/A 3 3 3 2
SURV1b 2 1 3 1 4 3 4 2
SURV2a 3 1 3 2 4 4 3 3
SURV2b 3 1 3 4 4 4 3 3
SURV2c 3 1 3 4 3 4 3 2
SURV3a 2 1 3 4 3 2 2 2
SURV3b 1 2 3 4 3 2 2 2
SURV3c 2 1 3 4 3 2 2 2
SURV4 3 1 3 4 3 3 4 3
SURV5 2 1 3 3 4 4 3 3
SURV6 2 1 3 3 2 3 3 3
Parameters in bold indicate parameters reviewed by an expert panel (Delphi surveys).
Parameters in bold italics indicate parameters based on literature reviews.
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dragging), SURV2b (active surveillance of vectors by trap-
ping of small rodents) and SURV1a (passive surveillance
of vectors of human origin). For the CONT model,
CONT0 (status quo – basic preventive communications),
CONT11 (human vaccination) and CONT3a (small scale
landscaping) were the three preferred interventions.
CONT6b (deer culling) and CONT6a (deer hunting)
were classified as the least preferable interventions un-
der both scenarios.
The GAIA plan decision map presented in Figure 2
shows the relative position of stakeholders with respect
to the decision axis (in red) and selected interventions
for the control model (CONT) under the “emergence
scenario”. Stakeholder’s positions (represented by S1-8
in this figure) are determined by the combination of the
intrinsic performance of interventions and by the stake-
holder’s weighting scheme. The closer a stakeholder is to
the decision axis (for example S2 and S7 in this map),
Table 4 Stakeholder weights (S1 to S8) under the emergence (EM) and the epidemic scenario (EP) for the surveillance
(SURV) and control (CONT) models
Criteria Weights
SURV model
S1 S2 S3 S4 S5 S6 S7 S8
EM EP EM EP EM EP EM EP EM EP EM EP EM EP EM EP
SUC SUC1 13 13 13 13 21 21 20 21 12 18 25 23 2 3 7 8
SUC2 13 13 13 13 14 0 20 21 12 18 8 11 8 12 21 16
SUC3 13 13 15 15 14 18 16 6 12 18 4 17 25 38 21 32
SUC4 13 13 10 10 21 21 24 12 24 18 26 11 5 3 21 24
Total 50 50 50 50 70 60 80 60 60 70 63 63 40 60 70 80
SEC SEC1 9 9 15 15 9 8 6 8 10 6 3 2 20 13 6 6
SEC2 9 9 15 15 0 0 2 2 10 6 10 10 20 13 6 4
SEC3 13 13 15 15 9 16 6 16 10 12 10 10 10 7 6 6
SEC4 19 19 5 5 12 16 6 14 10 6 15 15 10 7 12 4
Total 50 50 50 50 30 40 20 40 40 30 37 37 60 40 30 20
Total 100
Criteria CONT model
S1 S2 S3 S4 S5 S6 S7 S8
EM EP EM EP EM EP EM EP EM EP EM EP EM EP EM EP
PHC PHC1 8 8 21 21 20 25 12 20 16 25 10 4 25 35 30 30
PHC2 8 8 3 3 8 13 9 8 12 13 3 6 5 5 10 10
PHC3 8 8 6 6 12 13 9 12 12 13 8 16 10 10 10 10
Total 25 25 30 30 40 50 30 40 40 50 21 26 40 50 50 50
AEC AEC 1 13 13 15 10 5 3 13 13 5 5 13 14 15 15 10 10
AEC 2 13 13 15 10 5 3 13 13 5 5 13 14 10 10 10 10
Total 25 25 30 20 10 5 25 25 10 10 26 29 25 25 20 20
SIC SIC 1 18 18 5 10 10 4 15 10 13 10 4 4 10 10 11 9
SIC 2 8 8 5 10 10 6 10 15 13 10 4 9 5 5 5 6
Total 25 25 10 20 20 10 25 25 25 20 8 13 15 15 15 15
SEC SEC1 3 3 8 8 5 4 6 2 5 3 15 10 6 3 3 2
SEC2 3 3 8 8 0 0 2 1 3 2 15 5 6 3 3 2
SEC3 5 5 6 6 6 11 4 3 5 6 1 8 3 1 2 3
SEC4 9 9 3 3 11 11 4 2 5 4 8 4 2 1 4 3
SEC5 5 5 6 6 9 11 4 2 8 5 6 5 3 2 4 5
Total 25 25 30 30 30 35 20 10 25 20 45 32 20 10 15 15
Total 100
Bold font indicates the weight totals of criteria within each category.
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the more important their agreement with the best con-
sensual interventions (i.e. first ranked interventions),
and vice-versa. Interventions located close to the deci-
sion axis (CONT0, CONT3a and CONT11 in Figure 2)
are the preferred interventions for the group, and cor-
respond to the three best ranked interventions in Table 5.
A long decision axis indicates strong decision choice
power whereas a short decision axis indicates that
the compromise solution is close to the origin [42].
The worst ranked interventions are diametrically op-
posed to this axis (CONT6b, CONT6a, and CONT8). In
Figure 2, all eight stakeholders point toward the right
of the x axis, meaning that there are no major
discordances in their preferences. Stakeholder 6 and
stakeholder 8 are located somewhat apart from the rest
of the group’s preferences and had the most different
preferences and individual rankings. When examining
their individual rankings and intervention scores
(Table 6), their top three ranked interventions differ
slightly from those of the group ranking even though
the top three ranked group interventions are among
stakeholder 6 and 8’s four highest ranked interventions
(S8 even shares the same top three interventions as the
group, but in a different order). This information can be
used to help identify the stakeholders with distinct posi-
tions relative to the rest of the group, and represents a
Table 5 Group ranking of interventions for the surveillance (SURV) and control (CONT) models
SURV model Emergence Epidemic
Rank Score Rank Score
SURV2a – Active surveillance of vectors I. scapularis (flagging or dragging) 1 0.43 1 0.45
SURV2b – Active surveillance of vectors I. scapularis (trapping of small rodents) 2 0.40 2 0.42
SURV1a – Passive surveillance of vectors I. scapularis originating from humans 3 0.07 3 0.10
SURV6 – Sentinel surveillance of suspected Lyme cases in humans 4 0.03 5 −0.01
SURV1b – Passive surveillance of vectors I. scapularis originating from animals 5 0.00 4 0.04
SURV5 – Passive surveillance of human Lyme disease cases 6 −0.08 9 −0.14
SURV2c – Active surveillance of vectors I. scapularis (from hunted deer) 7 −0.13 7 −0.17
SURV3a – Passive surveillance of seropositivity to B. burgdorferi in domestic animals, funding of tests supported
by animal owners
8 −0.14 6 −0.12
SURV3c – Passive surveillance of seropositivity to B. burgdorferi in domestic animals, funding of tests supported
by the public sector
8 −0.14 6 −0.12
SURV3b – Passive surveillance of seropositivity to B .burgdorferi in domestic animals, funding of tests supported
by the private sector (industry)
9 −0.17 9 −0.14
SURV4 – Active surveillance of domestic animal cases of Lyme disease 10 −0.27 8 −0.34
CONT model Rank Score Rank Score
CONT0 – Status quo (basic preventive communication strategy) 1 0.43 1 0.39
CONT11 – Human vaccination1 2 0.31 2 0.31
CONT3a – Small scale landscaping (removal of tick habitats) 3 0.28 3 0.3
CONT10 – Excluding people from high-risk public areas 5 0.25 4 0.29
CONT12 – Making available special Lyme disease diagnostic/treatment clinic(s) 6 0.23 5 0.2
CONT4 – ‘4-poster’ device[47] 8 0.03 6 0.06
CONT7 – Exclusion of deer by fencing 9 −0.04 9 −0.02
CONT1a – Small scale acaricide application to kill free-living ticks 9 −0.04 7 0.01
CONT3b – Large scale Landscaping (removal of tick habitats) 10 −0.07 10 −0.03
CONT1b – Large scale acaricide application to kill free-living ticks 11 −0.08 8 −0.01
CONT2 – Application of desiccants/insecticidal soap 12 −0.14 11 −0.15
CONT5 – Feed-administered ivermectin to deer at bait stations to control ticks 13 −0.15 12 −0.17
CONT8 – ‘Damminix’ device[48] 14 −0.22 13 −0.25
CONT9 – Bait boxes to deliver a passive application of fipronil to rodents[49] 14 −0.22 13 −0.25
CONT6a – Deer hunting 15 −0.25 14 −0.29
CONT6b – Deer culling 16 −0.33 15 −0.31
1 Currently, no licensed vaccine exists for human use. Data used for this analysis come from [50]
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transparent articulation of decision considerations that
need to be further discussed to reach a better
consensus.
Intervention profiles graphically represent the relative
intrinsic performance of an intervention on each crite-
rion, independently of stakeholder expressed preferences
(weighting schemes) (Figure 3). A descriptive analysis of
the intervention profiles allows for a better understan-
ding of the trade-off to be considered in the overall deci-
sion and to identify complementary interventions. The Y
axis represents the score of the intervention for each cri-
terion. The first ranked intervention of the group,
CONT0 (status quo - basic preventive communications)
performs well on animal and environmental health cri-
teria and most operational criteria, but performs poorly
on the first two Public health criteria, PHC1 (reduction
of human case incidence) and PHC2 (reduction of ento-
mological risk). Conversely, the third ranked inter-
vention, CONT3a (small scale landscaping), performs
poorly on the AEC1 criterion (impact on habitat) and
SIC2 criterion (proportion of the population benefiting
from the intervention), but performs more efficiently on
the PHC1 and PHC2 criteria. A score of 1 on a criterion
(e.g. Criteria SEC4 (Complexity) and SEC5 (Impact on
organisation’s credibility) for CONT0) means that the
intervention has the best intrinsic performance for this
criterion among all interventions. By examining an in-
tervention’s profile, stakeholders can consider various
portfolios of interventions in order to create balanced
control programmes capable of addressing multiple
objectives.
A sensitivity analysis was performed to assess the
impact of a stakeholder’s weighting preferences on their
individual and group rankings. This analysis gives indica-
tions of the robustness of the results. Stability intervals
can be generated for each stakeholder for all criteria. For
example, as shown in Table 7, stakeholder 8 can change
the weight given to the SEC2 criteria (cost for the
Figure 2 GAIA decision map for CONT model under the emergence scenario (Delta = 96,6%, meaning that 96,6% of the information is
conserved in the two-dimensional representation of this map).
Table 6 Individual scores and ranking of interventions
under the emergence scenario in the control (CONT)
model for two stakeholders showing distinctive positions
in the GAIA decision map (stakeholder 6 (S6) and
stakeholder 8 (S8))
Intervention Group rank Score S6 Rank S6 Score S8 Rank S8
CONT0 1 0.53 1 0.3 3
CONT11 2 0.33 3 0.32 2
CONT3a 3 0.24 5 0.37 1
CONT10 5 0.37 2 0.15 5
CONT12 6 0.29 4 0.07 7
CONT4 8 −0.15 9 0.19 4
CONT1a 9 −0.11 8 0.09 6
CONT7 9 −0.18 11 0.02 9
CONT3b 10 −0.06 7 0.05 8
CONT1b 11 −0.22 12 0.02 9
CONT2 12 −0.04 6 −0.18 11
CONT5 13 −0.17 10 −0.12 10
CONT8 14 −0.26 13 −0.3 13
CONT9 14 −0.26 13 −0.3 13
CONT6a 15 −0.04 6 −0.37 14
CONT6b 16 −0.27 14 −0.29 12
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private sector) from 0 to 100% without this change affec-
ting the nature of the stakeholder’s top three ranked in-
terventions. However, any variations in the weight of the
“PHC1-Reduction in human cases incidence” criterion
beyond the range of 27.5 to 38.2 will result in a change
in nature of the top ranked interventions for stakeholder
3 indicating that the results are more sensitive to this
later criterion.
Figure 3 Six intervention profiles for the control (CONT) model under the “emergence scenario” (red: Public health criteria; green:
Environmental and animal health criteria; yellow: Social impact criteria; Blue: Strategic, economic and operational impact criteria).
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Discussion
This study demonstrated the application of a transparent
decision analysis method to identify decision criteria
and rank interventions for the control of Lyme disease in
Quebec as an illustration of its potential for the planning
and management of other complex public health issues.
To our knowledge, this is the first report of the use of
MCDA models to document stakeholder engagement in
the prioritization of Lyme disease management interven-
tions, and the first use of such an approach to analyse
public health interventions for an emerging zoonosis tack-
ling surveillance and control interventions in a compre-
hensive manner. One of the key observations resulting
from this study pertains to the list of criteria identified for
use in the different fields of interventions relating to Lyme
disease management. The general criteria categories dem-
onstrate the comprehensiveness of the models and lend
support to the use of MCDA methods as concrete applica-
tions of a “One Health” approach to zoonoses manage-
ment. The list of criteria could likely be generalized or
adapted for use with other vector-borne and zoonotic dis-
ease management problems. As an example, four of the
general categories (public health, animal and environmen-
tal health, social impacts and strategic, economic and op-
erational impacts) and several criteria identified with a
different group of stakeholders for two other MCDA
models developed to address communication strategies
for Lyme disease in Quebec by the research team were
identical to those identified for SURV and CONT models
(MCDA-Lyme Consortium, 2012, data not shown).
Furthermore, the criteria identified in this study corres-
pond directly to the dimensions which should be inte-
grated when analysing public policies, as identified and
recommended by the Canadian National Collaborating
Centre for Healthy Public Policy. This centre recently
published a method for synthesizing knowledge about
public policies, integrating six dimensions [43], which can
be directly correlated to our list of criteria as shown in
Table 8. This observation reinforces the fact that MCDA
methods have the potential to improve public health deci-
sions in line with the most recent national recommenda-
tions for evaluating public policies.
The observed variations in stakeholder’s weighting of
criteria was expected and can be explained as a result of
differences in values, perspectives, objectives and expertise
of the participating stakeholders, which is desirable within
a interdisciplinary and multi-sectoral approach. On the
other hand, changing the scenario from “emergence” to
“epidemic” was found to have little effect on the results,
which was unexpected for the research team. Although
some additional weighting was given to the public health
criteria by several stakeholders during the epidemic sce-
nario, the changes were not sufficient to produce clear dif-
ferences in the overall rankings of interventions between
scenarios. More weight for public health criteria and social
acceptability criteria during the epidemic scenario were
expected but not clearly observed in this study. One hy-
pothesis is that the description given of the epidemic sce-
nario was not sufficiently alarming to prompt important
differences in stakeholder weighting schemes between sce-
narios. Further analyses are needed under real epidemic
situations to validate these observations and to correlate
the findings of the MCDA analysis with actions that would
actually be implemented by stakeholders in such
situations.
In both models, performance evaluations of interven-
tions used qualitative categorical indicators for every
criterion. If ordinal scales were better suited for the evalu-
ation of certain criteria, as was the case for the SEC4
(complexity) criterion, numeric scales were used to in-
corporate more precision for other criteria, such as PHC1
(reduction in human case incidence), SEC1 and SEC2
(costs for the public and the private sectors). Moreover,
experts who contributed to the evaluation of certain pa-
rameters were also stakeholders on the MCDA process for
the CONT model. If this approach can be interesting for
the appropriation of the decision-making process by the
stakeholders, it could also introduce bias in the evaluation
of parameters, as preferences and expertise can vary
among them. This reflected the data quality which was
available at the time of the study and is the main limit of
this study. Lyme disease is emerging in Quebec, and very
few field studies have been performed to date. The data
quality evaluation performed in the models was useful for
identifying gaps in the scientific knowledge on public
health intervention efficacy and impacts in the Quebec
context. For the vast majority of interventions and criteria,
expert opinions were the most effective way to obtain the
data required to complete the models. More time and re-
sources could be used to counter this weakness: field
Table 7 Example of a sensitivity analysis using
stakeholder 8 (S8) weightings
Criteria Minimum weight Actual weight Maximum weight
PHC1 27.5 30 38.2
PHC2 7.4 10 15.8
PHC3 4.9 10 12.1
AEC1 0 10 12.6
AEC2 2 10 20.2
SIC1 0 10.5 33.4
SIC2 0 4.5 8.2
SEC1 0 3 20.1
SEC2 0 3 100
SEC3 0 1.5 17.6
SEC4 0 3.8 5.1
SEC5 0 3.8 8
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studies can be realized with the objective of increasing the
precision of performance evaluations in models. For
example, to assess the social acceptability of different con-
trol interventions, a Delphi survey was conducted among
the stakeholders. A more representative survey conducted
among the target population could increase the precision
of this performance measure. Furthermore, additional
analysis using the same MCDA model structure in other
geographical areas where Lyme disease epidemiology is
better characterised would provide an opportunity to va-
lidate the present model.
The first position occupied by CONT0 (status quo-basic
preventive communications) in the group ranking for the
CONT model was expected. The current communication
method in place involves the diffusion of general infor-
mation via the public organisation’s web interface. This
intervention is a baseline intervention upon which stake-
holders should build (but not eliminate) and include ad-
ditional interventions to improve Lyme management.
For the SURV model, the top two ranked interventions
were SURV2a (active surveillance of I. scapularis by
flagging or dragging) and SURV2b (active surveillance of
I. scapularis by trapping of small rodents). Again, this
was expected, because these two interventions are
considered the gold standard approach for Lyme vector
surveillance in Canada at the moment [31]. The rank
order of other SURV interventions should be interpreted
relative to these gold standards in the group ranking.
Despite small differences, the decision map for the
CONT model showed a good level of agreement bet-
ween stakeholders. SURV model revealed similar obser-
vations. Even if these results represent only the views of
a small group of stakeholders, greater differences could
have been expected. For example, from stakeholders
working for public environmental organisations, one
could have expected stronger preferences for low envir-
onmental impact interventions, when compared to pub-
lic health professionals. This observation demonstrates
that public health protection is still a strong commonly
held value, despite expertise and sectoral differences
between stakeholders. In this study, there were no repre-
sentatives from the general public or from public inte-
rest groups. This was a methodological choice made
after discussion with participating stakeholders and in
light of the exploratory nature of the objectives. The
inclusion of such groups, either as representatives of the
general public or of representatives of select interest
groups (for example members of the Canadian Lyme di-
sease foundation, CanLyme, or public park users) could
help diversify the range of expressed preferences and con-
cerns, an important dimension that should be considered
in public health decision making.
Analysis of the intervention profiles allowed identifica-
tion of complementary interventions for all models. The
strengths and weaknesses of an intervention can be eas-
ily identified with these types of analyses, and highlights
the need to include diverse interventions for an efficient
prevention programme capable of responding to mul-
tiple objectives.
Sensitivity analyses conducted were limited to iden-
tifying stability intervals for weights given to criteria by
each stakeholder. Other types of variation, for example
on performance parameters of interventions, have to be
simulated manually by changing parameters in the
matrix. This was not realised in a systematic manner for
this study but would be an interesting further step, par-
ticularly on parameters which are not supported by the
scientific literature. This could help to identify which
would be the more urgent knowledge gaps to tackle to
consolidate decision-making in this context. Except for
sensitivity analysis, the evaluation of a MCDA model’s
validity is rarely mentioned in the scientific literature
[44]. A framework for MCDA model validity testing
would be of great use for public health research. This
framework could include more extensive sensitivity
analysis on weights and parameters, as well as a stan-
dardised approach to assess how accurately the model
captures issues of importance to decision-makers.
Table 8 Alignment of Canadian National Collaboration
Centre for Health Public Policy dimensions with criteria
identified in the study
Canadian National
Collaborating Centre for
Healthy Public Policy
Study
Dimensions Criteria
Effectiveness PHC1 Reduction in incidence of human
cases
PHC2 Reduction in entomological risk
SUC1 Detection of zones where tick
populations are present
SUC2 Identification of zones where tick
populations are established
SUC3 Identification of Lyme endemic
zones
SUC4 Quality of data
Unintended effects PHC3 Impacts of adverse health effects
AEC1 Impact on habitat
AEC2 Impact on wildlife
Cost SEC1 Cost to the public sector
SEC2 Cost to the private sector
Equity SIC2 Proportion of the population
benefitting from intervention
Feasibility SEC3 Delay before results
SEC4 Complexity
SEC5 Impact on organisation’s credibility
Acceptability SIC1 Level of public acceptance
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Building on this study’s experience, the authors believe
that MCDA approaches offer a structured and systematic
process for identifying gaps in the scientific knowledge
relating to important decision issues, and can be of great
use to guide research priorities in public health in a con-
text of finite and sometimes scarce resources. Another
major advantage of formal decision analysis methods is
the long-term utility it can confer to decision-makers.
Once the matrix is completed (i.e. criteria, interventions
and performances have been identified), stakeholders can
re-evaluate their weights on each criteria as the epidemio-
logical situation of the disease changes, and can observe
the impacts on intervention prioritization. Used in this
manner, MCDA models could be adapted and potentially
used with real-time decision-making methods.
Some challenges arose during the study. First, depen-
ding on the scope and depth of the analysis, the MCDA
process can be time-consuming: given the participatory
approach used in this study, a significant time commit-
ment was needed for meetings and discussions. Experts
recommend a minimum of six months to complete an
MCDA process with participative components. However,
in this case, two years were needed to put together the
research team and complete the study. Public health
experts had no experience with MCDA methods, and
the learning process demanded time and resources. This
is not surprising and prolonged timelines have been
observed in other multidisciplinary teams [7]. As such,
MCDA approaches may be best suited for strategic pub-
lic health planning rather than for daily decisions and
emergency situations, unless MCDA models are already
developed. Creating weighting schemes was also challen-
ging and not intuitive for the majority of stakeholders.
Individual support was needed in several cases, and par-
ticipants needed a good understanding of the MCDA
process to perform the weighting. Methods exist to
facilitate the weighting process in MCDA approaches,
such as the use of card sets to help order criteria before
attributing numerical values [45]. We strongly recom-
mend using them to increase the validity of analysis.
The participative approach used in identifying key stake-
holders, criteria and potential interventions contributed to
building a comprehensive structure of the key issues in
need of consideration and helped capture the complexity
of the health problem. The use of a participatory approach
in this study also had an interesting and important con-
sequence: the learning process put stakeholders from dif-
ferent sectors and organisations together and enabled
mutual learning about each other’s organisation’s issues
and priorities. During this project, stakeholders met bet-
ween two to five times within the year to complete the
process. We believe that this approach reinforces an inter-
disciplinary and multi-sectoral approach to public health
management, leading to institutional empowerment.
These long-term outcomes were previously observed in
several examples of participatory approaches in health
research [46].
Conclusions
This study presented the results of an MCDA approach
for the management of a complex public health issue - an
emerging zoonosis - using a study of Lyme disease ma-
nagement in Quebec, Canada. Results showed that despite
different weighting schemes among stakeholders, both
models revealed a good level of agreement with regards to
preferred interventions for surveillance and control of
Lyme disease. The reliance primarily on expert opinion
for development of the performance matrices underscores
the need to enhance scientific knowledge on issues of
importance for decision-making for Lyme management in
Quebec. Overall, explicit decision analysis methods pre-
sent themselves as an interesting systematic approach for
the management of complex public health issues and par-
ticularly for emerging infectious diseases arising from
human populations interacting with animals and the en-
vironment. Future steps should include an assessment of
the applicability and usefulness of the proposed models
for program-level decision support pertinent to the pre-
vention and control of Lyme disease in Canada. Moreover,
building on the outcome of this project, future projects
should evaluate the utility of MCDA for structuring a for-
mal decision analysis approach for other complex public
health issues (e.g.: prevention of foodborne and water-
borne diseases, antimicrobial resistance, influenza, and
environmental health issues) as well as within various on-
going processes and prioritization settings targeting effec-
tive multi-sectoral engagement. The development of a
methodological framework for MCDA model validation
would also be of great interest for the public health sector.
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